ArticleClinical therapeutics2023

Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, and Sodium-Glucose Cotransporter-2 Inhibitors and COVID-19 Outcomes.

Andreana Foresta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.